Approval Probability
TA Base Rate
Adjusted LOA
ML Risk
Medical Food Supplement, standard hospital food · 1 trial · 1 indication
| Arm | Type | Description |
|---|---|---|
| Medical Food Supplement | EXPERIMENTAL | Medical food supplement to be given in divided portions in morning, afternoon and evening |
| standard hospital food | ACTIVE_COMPARATOR | standard hospital diet |
| Name | Type | Description |
|---|---|---|
| Medical Food Supplement | OTHER | Medical Food Supplement to be given in divided portions in morning, afternoon and evening |
| standard hospital food | OTHER | standard hospital diet ad. lib. |
Inclusion Criteria: * Subject is \> 45 years of age. * Subject is a male or a non-pregnant, non-lactating female, at least 6 weeks postpartum prior to screening visit. * Subject plans to undergo hip fracture surgery. * Subject has anticipated length of hospital stay of at least 4 weeks. Subject is ...
| Company | Ticker | Trials | Lead Phase | Drugs |
|---|---|---|---|---|
| Zimmer Biomet Holdings, Inc. | ZBH | 23 | N/A | Undisclosed |
| Stryker Corporation | SYK | 4 | - | Undisclosed |
| Johnson & Johnson | JNJ | 1 | N/A | Undisclosed |
| Orthofix Medical, Inc. | OFIX | 1 | - | Undisclosed |
| Cooper Companies, Inc. | COO | 1 | - | Undisclosed |
Medical Food Supplement, standard hospital food is a nutritional product being studied for use in patients recovering from hip fracture surgery. It is intended for hospitalized patients during their recovery period. The product is currently in Phase 3 clinical development and remains investigational for this use.
Abbott Laboratories (NYSE: ABT) is developing Medical Food Supplement, standard hospital food. The company is conducting clinical research to evaluate the product's effects in patients recovering from hip fracture surgery.
Medical Food Supplement, standard hospital food is in Phase 3 clinical development. One Phase 3 trial has been completed, and the product is not yet approved for the studied indication. It remains an investigational product for use in hip fracture recovery.
Medical Food Supplement, standard hospital food has one completed Phase 3 trial, NCT01011608, titled "Effect of a Medical Food Supplement in Hospitalized Patients Recovering From Surgery." The trial enrolled 127 patients with hip fracture in Russia and was completed.
Medical Food Supplement, standard hospital food is a specific nutritional product being studied as an addition to standard hospital food. The trial compared the supplement against an active control, meaning patients received either the supplement or standard care during recovery from hip fracture surgery.